Brief: Medigene Announces Positive Results From Follow-Up Of AML Patients In DC Vaccine Trial

Medigene AG

08/02/2021 15:07

Feb 8 (Reuters) - MEDIGENE AG  MDG1k.DE :
    * FURTHER ENCOURAGING RESULTS FROM LONG-TERM FOLLOW-UP OF
AML
PATIENTS IN DC VACCINE TRIAL
    * RESULTS INDICATE A DURABILITY OF POTENTIAL CLINICAL
BENEFITS FOR
PATIENTS RECEIVING DC VACCINE, WHICH ALSO HAD A FAVORABLE
SAFETY/TOLERABILITY PROFILE

Source text for Eikon:  ID:nNDLbMTpgf 
Further company coverage:  MDG1k.DE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))